<DOC>
	<DOCNO>NCT02085161</DOCNO>
	<brief_summary>The primary objective study explore effect treatment orally inhaled tiotropium + olodaterol fix dose combination without exercise training , tiotropium compare placebo , top behavioural modification improve exercise capacity patient COPD</brief_summary>
	<brief_title>To Evaluate Effect Inhaled Medication Together With Exercise Activity Training Exercise Capacity Daily Activities Patients With Chronic Lung Disease With Obstruction Airways</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : All patient must sign informed consent consistent International Conference Harmonisation Technical Requirements Registration Pharmaceuticals Human Use ( ICH ) Good Clinical Practice ( GCP ) guideline prior participation trial , include medication washout restriction . All patient must diagnosis chronic obstructive pulmonary disease must meet follow spirometric criterion : Patients must relatively stable airway obstruction postbronchodilator force expiratory volume one second &gt; =30 % &lt; 80 % predict normal ; Global Initiative Chronic Obstructive Lung Disease grade II III , postbronchodilator Tiffeneau index &lt; 70 % Visit 1 . Male female patient , age &gt; =40 year &lt; =75 year . Patients must current exsmokers smoke history 10 pack year . Patients never smoke cigarette must exclude . Exclusion criterion : Patients significant disease chronic obstructive pulmonary disease . Patients clinically relevant abnormal baseline haematology , blood chemistry , urinalysis . Patients history asthma . A diagnosis thyrotoxicosis . A diagnosis paroxysmal tachycardia ( &gt; 100 beat per minute ) . A history myocardial infarction within 1 year screen visit . Unstable lifethreatening cardiac arrhythmia . Hospitalized heart failure within past year . Known active tuberculosis . A malignancy patient undergone resection , radiation therapy chemotherapy within last five year . A history lifethreatening pulmonary obstruction patient chronic respiratory failure . A history cystic fibrosis . Clinically evident bronchiectasis . A history significant alcohol drug abuse . Any contraindication exercise test . Patients undergone thoracotomy pulmonary resection . Patients treat oral ßadrenergics . Patients treat oral corticosteroid medication unstable dos ( i.e. , less six week stable dose ) dose excess equivalent 10 mg prednisone per day 20 mg every day . Patients regularly use daytime oxygen therapy one hour per day investigator opinion unable abstain use oxygen therapy clinic visit . Patients complete pulmonary rehabilitation program six week prior screen visit patient currently pulmonary rehabilitation program . Patients limitation exercise performance result factor fatigue exertional dyspnoea , arthritis leg , angina pectoris claudication morbid obesity . Patients take investigational drug within one month six half life ( whichever great ) prior screen visit . Patients know hypersensitivity ßadrenergics drug , anticholinergic drug , benzalkonium chloride , disodium edentat , component Respimat® inhalation solution delivery system . Pregnant nursing woman . Women childbearing potential use highly effective method birth control . Patients previously randomize study currently participate another study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>